Obinutuzumab as bridging therapy for successful manufacturing of axicabtagene ciloleucel for transformed follicular lymphoma with circulating cells

Mohamed A. Kharfan-Dabaja, Michael D. Jain, Sonikpreet Aulakh, Ernesto Ayala, Abba C. Zubair, Han W. Tun, Hien D. Liu, Frederick L. Locke, Julio C. Chavez

Research output: Contribution to journalLetterpeer-review

Original languageEnglish (US)
Pages (from-to)E245-E247
JournalAmerican journal of hematology
Volume94
Issue number9
DOIs
StatePublished - 2019

ASJC Scopus subject areas

  • Hematology

Cite this